Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200
2019
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 80
As coordinator: 14
As participant: 55
Sole participant: 11
Coordinator / Participant Ratio: 0.25^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2023	12.147.314	6.771.571	6.300.750	2	1
2022	6.606.932	44.575.558	8.233.163	4	7
2021	11.639.913	61.552.405	13.719.076	6	14
2020	9.656.548	302.464.789	13.851.591	5	19
2019	23.998.245	186.376.524	14.323.634	8	14

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	18
CHARITE UNIVERSITAETSMEDIZIN BERLIN	12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	11
UNIVERSITY OF COPENHAGEN	11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	10
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	10
KATHOLIEKE UNIVERSITEIT LEUVEN	10
PERCUROS BV	9
THE UNIVERSITY OF EDINBURGH	9
UNIVERSITY OF OSLO	9
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	8
EUROPEAN MOLECULAR BIOLOGY LABORATORY	8
KAROLINSKA INSTITUTE	8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	8
UNIVERSITY OF CAMBRIDGE	8
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG	7
JANSSEN PHARMACEUTICA NV	7
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	7
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	7
THE UNIVERSITY OF MANCHESTER	7
UNIVERSITAT DE BARCELONA	7
UNIVERSITY COLLEGE LONDON	7
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	6
COMMISSARIAT A L'ENERGIE ATOMIQUE	6
EATRIS ERIC	6
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	6
HEINRICHHEINEUNIVERSITAET DUESSELDORF	6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	6
ISTITUTO SUPERIORE DI SANITA	6
KING'S COLLEGE LONDON	6
OSLO UNIVERSITETSSYKEHUS HF	6
PFIZER LIMITED	6
SANOFIAVENTIS	6
THE UNIVERSITY OF TUEBINGEN	6
UNIVERSITAETSKLINIKUM FREIBURG	6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	6
UNIVERSITEIT UTRECHT	6
UNIVERSITY OF DUNDEE	6
UNIVERSITY OF HELSINKI	6
ACADEMISCH ZIEKENHUIS GRONINGEN	5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	5
DANMARKS TEKNISKE UNIVERSITET	5
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT	5
MASARYKOVA UNIVERZITA	5
MEDIZINISCHE UNIVERSITAET WIEN	5
MEDIZINISCHE UNIVERSITAT INNSBRUCK	5
NOVARTIS PHARMA	5
SORBONNE UNIVERSITE	5
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	5
STICHTING RADBOUD UNIVERSITEIT	5
TECHNISCHE UNIVERSITAET MUENCHEN	5
UNIVERSIDAD DE GRANADA	5
UNIVERSITA DEGLI STUDI DI CAMERINO	5
UNIVERSITAET ZUERICH	5
UNIVERSITAETSKLINIKUM AACHEN	5
UNIVERSITE D'AIX MARSEILLE	5
UNIVERSITEIT ANTWERPEN	5
UNIVERSITEIT MAASTRICHT	5
UNIVERSITY OF AARHUS	5
UNIVERSITY OF WALES CARDIFF	5
ABBVIE INC	4
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	4
ASTRAZENECA	4
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	4
CENTRE DE REGULACIO GENOMICA	4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	4
CONSIGLIO NAZIONALE DELLE RICERCHE	4
DRESDEN UNIVERSITY OF TECHNOLOGY	4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA	4
GOETEBORGS UNIVERSITET	4
INSTITUT PASTEUR	4
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES	4
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW	4
LUND UNIVERSITY	4
MEDIZINISCHE UNIVERSITAT GRAZ	4
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	4
SERVICIO MADRILENO DE SALUD	4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	4
TAKEDA PHARMACEUTICALS INTERNATIONAL	4
TECOBIOSCIENCES	4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN	4
THE UNIVERSITY OF SHEFFIELD	4
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'	4
UNIVERSITA DEGLI STUDI DI SIENA	4
UNIVERSITA DEGLI STUDI DI TORINO	4
UNIVERSITY OF BERGEN	4
UNIVERSITY OF EASTERN FINLAND	4
UNIVERSITY OF GLASGOW	4
UNIVERSITY OF LEEDS	4
UNIVERSITY OF NEWCASTLE UPON TYNE	4
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE	4
WAGENINGEN UNIVERSITY	4
AUSTRIAN RESEARCH CENTERS SIEBERDORF	3
BAYER	3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	3
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES	3
CONCENTRIS RESEARCH MANAGEMENT	3
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE	3
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY	3

Constancy:

Total number of partners: 1525
Partner loyalty:
Frequent Partner: (> 2 projects): 696
Rare Partner: 829
Frequent / Rare Partner Ratio: 0.84

Project overview:

Start date	Project	acronym	role	funding	partners
2023-01-01	GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION	GlycanTrigger	participant	6.771.571	9
2023-01-01	Implementation research on the tailored, multidisciplinary NCD prevention package FRESHAIR4LIFE: Targeting tobacco and air pollution exposure in mid- to late adolescents in disadvantaged populations	FRESHAIR4LIFE	coordinator	2.149.814	13
2023-01-01	Glycans as Master Switches of B Cell Activity in Autoimmunity	GlycanSwitch	coordinator	9.997.500	3
2022-12-01	GLYCOTwinning: Building Networks to Excel in Glycosciences	GLYCOTwinning	participant	1.231.375	4
2022-12-01	Maximising Impact of Prescription Drugs in Rheumatoid Arthritis	SQUEEZE	participant	8.602.316	13
2022-11-01	Identification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches	ColoMARK	participant	2.656.678	16
2022-10-01	Reversing vaccine hypo-responsiveness	REVERSE	coordinator	2.372.681	1
2022-10-01	DNA replication at the heart of cell fate decisions and cancer development	RepliFate	participant	2.650.313	21
2022-09-01	Gene Therapy of Rare Diseases	GetRadi	participant	2.785.810	14
2022-06-01	Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection.	ReCHISVac	coordinator	234.530	2
2022-06-01	Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions	SafePolyMed	participant	5.650.443	13
2022-06-01	Mechanisms at the interface of DNA damage repair and transcription	STOP-FIX-GO	coordinator	1.999.764	1
2022-05-01	Adopting ISO 82304-2 and a trusted EU mHealth label for a single market that enables patients, citizens, health professionals, systems and authorities to benefit from a healthy supply of useful apps.	Label2Enable	coordinator	1.999.957	14
2022-02-01	Integrated Services for Infectious Disease Outbreak Research	ISIDORe	participant	20.998.624	154
2021-09-01	Human mini hearts: looking for culprits and victims in cardiac disease	Mini-HEART	participant	2.000.000	2
2021-09-01	Innovations to accelerate vaccine development and manufacture	Inno4Vac	participant	18.600.000	41
2021-09-01	Portable, accessible and sustainable magnetic resonance	PASMAR	coordinator	2.493.715	1
2021-06-01	Psychiatric Ratings using Intermediate Stratified Markers 2	PRISM 2	participant	3.980.906	18
2021-05-01	A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIA	STOPSTORM	participant	7.161.437	31
2021-05-01	PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL	TTV GUIDE TX	participant	6.099.831	21
2021-04-01	Coordinating Research and Evidence for Medical Devices	CORE-MD	participant	2.360.978	23
2021-04-01	Exploitation of a low-field scanner for physiotherapy and rheumatology	PR scanner	participant	100.000	2
2021-03-01	NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242	A-TANGO	participant	5.999.999	14
2021-03-01	HealthyCloud – Health Research & Innovation Cloud	HealthyCloud	participant	2.999.975	26
2021-03-01	APC/C substrates: how are they disengaged from their non-degraded binding partners?	UbiBranch	coordinator	187.572	1
2021-03-01	European Rare dIsease research Coordination and support Action	ERICA	coordinator	2.313.809	27
2021-03-01	Nanoparticle-Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia (DRG)	PIANO	participant	4.093.425	11
2021-02-01	Embedding a comprehensive ethical dimension to organoïd-based research and resulting technologies	HYBRIDA	participant	2.995.785	8
2021-02-01	European consortium for communicating gene- and cell-based therapy information.	EuroGCT	participant	1.999.784	47
2021-02-01	The dark side of the genome: systematically studying the biology of repressive elements—silencers—in the human genome	Silencer	coordinator	1.750.000	1
2021-01-01	Viruses and Epitranscriptomics: seeking novel targets for antiviral therapy	EpiViral	participant	878.446	4
2021-01-01	Targeting auto-reactive B-cells by vaccination to cure human auto-immune disease	Target to B-cure	coordinator	2.500.000	1
2021-01-01	Drug repurposing and discovery multidisciplinary training network	DRUGtrain	coordinator	2.394.817	8
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-10-01	Immunological incompatibility as a basis for cancer curing and vaccination	ULISES	participant	2.977.160	11
2020-09-01	Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM	RadoNorm	participant	18.000.000	60
2020-09-01	Biosafety assays for the diagnosis and prediction of drug-related complement pathology	Biosafety	participant	900.000	6
2020-09-01	Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling	ACQUIRE	coordinator	150.000	1
2020-08-01	Indo-European Consortium for Next Generation Influenza Vaccine Innovation	INCENTIVE	participant	9.974.294	21
2020-06-01	DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE	TRANSVAC-DS	participant	1.879.216	28
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	23
2020-05-01	Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA	INNODIA HARVEST	participant	5.999.055	41
2020-05-01	Staff Exchange for Novel applications in 19f magnetic resonance imaging	SENATOR	participant	1.541.000	11
2020-04-01	proactive monitoring of cancer as an alternative to surgery	PRISAR2	participant	2.484.000	25
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2020-04-01	Human Brain Project Specific Grant Agreement 3	HBP SGA3	participant	150.000.000	162
2020-04-01	Swift COronavirus therapeutics REsponse	SCORE	coordinator	2.576.063	10
2020-04-01	Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine	Prevent-nCoV	participant	2.728.340	9
2020-03-01	Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe	ISLET	participant	7.999.999	8
2020-03-01	Critical solutions for elderly well-being	RISE-WELL	coordinator	2.691.279	7

overview shows latest 50 from 80 projects (2019-01-01 - 2024-12-31)
A full list of projects can be found here:

Alias institution names:

LEIDS UNIVERSITAIR MEDISCH CENTRUM

LEIDS UNIVERSITAIR MEDISCH CENTRUM - Netherlands